Endogenous nitric oxide synthesis: Biological functions and pathophysiology

References

• Green L.C., Tannenbaum S.R., Goldman P. Nitrate synthesis in the germfree and conventional rat. Science 1981; 212: 56–56
   PubMed Web of Science ®Google Scholar
• Green L.C., Ruiz de Luzuriaga K., Wagner D.A., Rand W., Istfan N., Young V.R., Tannenbaum S.R. Nitrate biosynthesis in man. Proceedings of the National Academy of Sciences of the United States of America 1981; 78: 7764–7764
   PubMed Web of Science ®Google Scholar
• Wagner D.A., Young V.R., Tannenbaum S.R., Schultz D.S., Deen W.M. Mammalian nitrate biochemistry: metabolism and endogenous synthesis. Iarc Scientific Publications 1984; 34: 247–247
   Google Scholar
• Hegesh E., Shiloah J. Blood nitrates and infantile methemoglobinemia. Clinica Chimica Acta 1982; 125: 107–107
   PubMed Web of Science ®Google Scholar
• Wagner D.A., Young V.R., Tannenbaum S.R. Mammalian nitrate biosynthesis: incorporation of 15NH3 into nitrate is enhanced by endotoxin treatment. Proceedings of the National Academy of Sciences of the United States of America 1983; 80: 4518–4518
   PubMedGoogle Scholar
• Stuehr D.J., Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America 1985; 82: 7738–7738
   PubMed Web of Science ®Google Scholar
• Stuehr D.J., Marletta M.A. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Research 1987; 47: 5590–5590
   PubMed Web of Science ®Google Scholar
• Stuehr D.J., Marletta M.A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. Journal of Immunology 1987; 139: 518–518
   PubMed Web of Science ®Google Scholar
• Marletta M.A., Yoon P.S., Iyengar R., Leaf C.D., Wishnok J.S. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706–8706
   PubMed Web of Science ®Google Scholar
• Hibbs J.B., Jr., Vavrin Z., Taintor R.R. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. Journal of Immunology 1987; 138: 550–550
   PubMed Web of Science ®Google Scholar
• Hibbs J.B., Jr., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987; 235: 473–473
   PubMed Web of Science ®Google Scholar
• Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–373
   PubMed Web of Science ®Google Scholar
• Griffith T.M., Edwards D.H., Lewis M.J., Newby A.C., Henderson A.H. The nature of endothelium-derived vascular relaxant factor. Nature 1984; 308: 645–645
   PubMed Web of Science ®Google Scholar
• Cocks T.M., Angus J.A., Campbell J.H., Campbell G.R. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. Journal of Cellular Physiology 1985; 123: 310–310
   PubMed Web of Science ®Google Scholar
• Rapoport R.M., Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circulation Research 1983; 52: 352–352
   PubMed Web of Science ®Google Scholar
• Arnold W.P., Mittal C.K., Katsuki S., Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proceedings of the National Academy of Sciences of the United States of America 1977; 74: 3203–3203
   PubMed Web of Science ®Google Scholar
• Ignarro L.J., Lippton H., Edwards J.C., Baricos W.H., Hyman A.L., Kadowitz P.J., Gruetter C.A. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. Journal of Pharmacology and Experimental Therapeutics 1981; 218: 739–739
   PubMed Web of Science ®Google Scholar
• Craven P.A., DeRubertis F.R. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. Journal of Biological Chemistry 1978; 253: 8433–8433
   PubMed Web of Science ®Google Scholar
• Ignarro L.J., Degnan J.N., Baricos W.H., Kadowitz P.J., Wolin M.S. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochimica et Biophysica Acta 1982; 718: 49–49
   PubMed Web of Science ®Google Scholar
• Furchgott R.F. Vasodilation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium, P.M. Vanhoutte. Raven Press, New York 1988; 401–401
   Google Scholar
• Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences of the United States of America 1987; 84: 9265–9265
   PubMed Web of Science ®Google Scholar
• Ignarro L.J., Byrns R.E., Wood K.S. Vasodilation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium, P.M. Vanhoutte. Raven Press, New York 1988; 427–427
   Google Scholar
• Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524–524
   PubMed Web of Science ®Google Scholar
• Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664–664
   PubMed Web of Science ®Google Scholar
• Palmer R.M., Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochemical and Biophysical Research Communications 1989; 158: 348–348
   PubMed Web of Science ®Google Scholar
• Azuma H., Ishikawa M., Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. British Journal of Pharmacology 1986; 88: 411–411
   PubMed Web of Science ®Google Scholar
• Furlong B., Henderson A.H., Lewis M.J., Smith J.A. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. British Journal of Pharmacology 1987; 90: 687–687
   PubMed Web of Science ®Google Scholar
• Radomski M.W., Palmer R.M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057–1057
   PubMed Web of Science ®Google Scholar
• Radomski M.W., Palmer R.M., Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. British Journal of Pharmacology 1987; 92: 639–639
   PubMed Web of Science ®Google Scholar
• Aisaka K., Gross S.S., Griffith O.W., Levi R. NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?. Biochemical and Biophysical Research Communications 1989; 160: 881–881
   PubMed Web of Science ®Google Scholar
• Whittle B.J., Lopez-Belmonte J., Rees D.D. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. British Journal of Pharmacology 1989; 98: 646–646
   PubMed Web of Science ®Google Scholar
• Rees D.D., Palmer R.M., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proceedings of the National Academy of Sciences of the United States of America 1989; 86: 3375–3375
   PubMed Web of Science ®Google Scholar
• Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997–997
   PubMed Web of Science ®Google Scholar
• Vallance P., Collier J., Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovascular Research 1989; 23: 1053–1053
   PubMed Web of Science ®Google Scholar
• Deguchi T. Endogenous activating factor for guanylate cyclase in synaptosomal-soluble fraction of rat brain. Journal of Biological Chemistry 1977; 252: 7617–7617
   PubMedGoogle Scholar
• Deguchi T., Yoshioka M. L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. Journal of Biological Chemistry 1982; 257: 10147–10147
   PubMedGoogle Scholar
• Knowles R.G., Palacios M., Palmer R.M., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proceedings of the National Academy of Sciences of the United States of America 1989; 86: 5159–5159
   PubMed Web of Science ®Google Scholar
• Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336: 385–385
   PubMed Web of Science ®Google Scholar
• Ferrendelli J.A., Chang M.M., Kinscherf D.A. Elevation of cyclic GMP levels in central nervous system by excitatory and inhibitory amino acids. Journal of Neurochemistry 1974; 22: 535–535
   PubMedGoogle Scholar
• Garthwaite J., Balazs R. Excitatory amino acid-induced changes in cyclic GMP levels in slices and cell suspensions from the cerebellum. Advances in Biochemical Psychopharmacology 1981; 27: 317–317
   PubMedGoogle Scholar
• Bredt D.S., Snyder S.H. Nitric oxide media glutamate-linked enhancement of cGMP levels in the cerebellum. Proceedings of the National Academy of Sciences of the United States of America 1989; 86: 9030–9030
   PubMed Web of Science ®Google Scholar
• Garthwaite J., Garthwaite G., Palmer R.M., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. European Journal of Pharmacology 1989; 172: 413–413
   PubMed Web of Science ®Google Scholar
• Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proceedings of the National Academy of Sciences of the United States of America 1990; 87: 682–682
   PubMed Web of Science ®Google Scholar
• Mayer B., John M., Böhme E. Purification of a Ca2+/calmodulin-dependent nitric oxide synthase from porcine cerebellum. Cofactor-role of tetrahydrobiopterin. FEBS Letters 1990; 277: 215–215
   PubMed Web of Science ®Google Scholar
• Schmidt H.H.H.W., Pollock J.S., Nakane M., Gorsky L.D., Forstermann U., Murad F. Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 365–365
   PubMed Web of Science ®Google Scholar
• Hevel J.M., White K.A., Marletta M.A. Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. Journal of Biological Chemistry 1991; 226: 22789–22789
   Google Scholar
• Yui Y., Hattori R., Kosuga K., Eizawa H., Hiki K., Kawai C. Purification of nitric oxide synthase from rat macrophages. Journal of Biological Chemistry 1991; 266: 12544–12544
   PubMed Web of Science ®Google Scholar
• Stuehr D.J., Cho H.J., Kwon N.S., Weise M.F., Nathan C.F. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 7773–7773
   PubMed Web of Science ®Google Scholar
• Evans T., Carpenter A., Cohen J. Purification of a distinctive form of endotoxin-induced nitric oxide synthase from rat liver. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 5361–5361
   PubMed Web of Science ®Google Scholar
• Pollock J.S., Forstermann U., Mitchell J.A., Warner T.D., Schmidt H.H., Nakane M., Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 10480–10480
   PubMed Web of Science ®Google Scholar
• Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714–714
   PubMed Web of Science ®Google Scholar
• Nakane M., Schmidt H.H., Pollock J.S., Forstermann U., Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Letters 1993; 316: 175–175
   PubMed Web of Science ®Google Scholar
• Sessa W.C., Harrison J.K., Barber C.M., Zeng D., Durieux M.E., D'Angelo D.D., Lynch K.R., Peach M.J. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. Journal of Biological Chemistry 1992; 267: 15274–15274
   PubMed Web of Science ®Google Scholar
• Lamas S., Marsden P.A., Li G.K., Tempst P., Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 6348–6348
   PubMed Web of Science ®Google Scholar
• Janssens S.P., Shimouchi A., Quertermous T., Bloch D.B., Bloch K.D. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. Journal of Biological Chemistry 1992; 267: 14519–14519
   PubMed Web of Science ®Google Scholar
• Lyons C.R., Orloff G.J., Cunningham J.M. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. Journal of Biological Chemistry 1992; 267: 6370–6370
   PubMed Web of Science ®Google Scholar
• Xie Q.W., Cho H.J., Calaycay J., Mumford R.A., Swiderek K.M., Lee T.D., Ding A., Troso T., Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225–225
   PubMed Web of Science ®Google Scholar
• Lowenstein C.J., Glatt C.S., Bredt D.S., Snyder S.H. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 6711–6711
   PubMed Web of Science ®Google Scholar
• Geller D.A., Lowenstein C.J., Shapiro R.A., Nussler A.K., Di Silvio M., Wang S.C., Nakayama D.K., Simmons R.L., Snyder S.H., Billiar T.R. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 3491–3491
   PubMed Web of Science ®Google Scholar
• Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 1991; 43: 109–109
   PubMed Web of Science ®Google Scholar
• Pufahl R.A., Nanjappan P.G., Woodard R.W., Marletta M.A. Mechanistic probes of N-hydroxylation of L-arginine by the inducible nitric oxide synthase from murine macrophages. Biochemistry 1992; 31: 6822–6822
   PubMed Web of Science ®Google Scholar
• Feldman P.L., Griffith O.W., Hong H., Stuehr D.J. Irreversible inactivation of macrophage and brain nitric oxide synthase by L-NG-methylarginine requires NADPH-dependent hydroxylation. Journal of Medicinal Chemistry 1993; 36: 491–491
   PubMed Web of Science ®Google Scholar
• Dwyer M.A., Bredt D.S., Snyder S.H. Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo. Biochemical and Biophysical Research Communications 1991; 176: 1136–1136
   PubMed Web of Science ®Google Scholar
• Klatt P., Schmidt K., Uray G., Mayer B. Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of N omega-hydroxy-L-arginine as an intermediate. Journal of Biological Chemistry 1993; 268: 14781–14781
   PubMed Web of Science ®Google Scholar
• Zhang Z.G., Reif D., Macdonald J., Tang W.X., Kamp D.K., Gentile R.J., Shakespeare W.C., Murray R.J., Chopp M. ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. Journal of Cerebral Blood Flow and Metabolism 1996; 16: 599–599
   PubMed Web of Science ®Google Scholar
• Stuehr D.J., Kwon N.S., Nathan C.F., Griffith O.W., Feldman P.L., Wiseman J. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. Journal of Biological Chemistry 1991; 266: 6259–6259
   PubMed Web of Science ®Google Scholar
• White K.A., Marletta M.A. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 1992; 31: 6627–6627
   PubMed Web of Science ®Google Scholar
• Griffith O.W., Stuehr D.J. Nitric oxide synthases: properties and catalytic mechanism. Annual Review of Physiology 1995; 57: 707–707
   PubMed Web of Science ®Google Scholar
• Crane B.R., Arvai A.S., Ghosh D.K., Wu C., Getzoff E.D., Stuehr D.J., Tainer J.A. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 1998; 279: 2121–2121
   PubMed Web of Science ®Google Scholar
• Pou S., Pou W.S., Bredt D.S., Snyder S.H., Rosen G.M. Generation of superoxide by purified brain nitric oxide synthase. Journal of Biological Chemistry 1992; 267: 24173–24173
   PubMed Web of Science ®Google Scholar
• Vorherr T., Knöpfel L., Hofmann F., Mollner S., Pfeuffer T., Carafoli E. The calmodulin binding domain of nitric oxide synthase and adenylyl cyclase. Biochemistry 1993; 32: 6081–6081
   PubMedGoogle Scholar
• Burnstock G. Review lecture. Neurotransmitters and trophic factors in the autonomic nervous system. Journal of Physiology 1981; 313: 1–1
   PubMed Web of Science ®Google Scholar
• Gillespie J.S., Liu X.R., Martin W. The effects of L-arginine and NG-monomethyl L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. British Journal of Pharmacology 1989; 98: 1080–1080
   PubMedGoogle Scholar
• Li C.G., Rand M.J. Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clinical and Experimental Pharmacology Physiology 1989; 16: 933–933
   PubMedGoogle Scholar
• Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768–768
   PubMed Web of Science ®Google Scholar
• Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75: 1273–1273
   PubMed Web of Science ®Google Scholar
• Chung E., Curtis D., Chen G., Marsden P.A., Twells R., Xu W., Gardiner M. Genetic evidence for the neuronal nitric oxide synthase gene (NOSI) as a susceptibility locus for infantile pyloric stenosis. American Journal of Human Genetics 1996; 58: 363–363
   PubMedGoogle Scholar
• Iadecola C., Zhang F., Xu X. Role of nitric oxide synthase-containing vascular nerves in cerebrovasodilation elicited from cerebellum. American Journal of Physiology 1993; 264: R738–R738
   PubMedGoogle Scholar
• Nozaki K., Moskowitz M.A., Maynard K.I., Koketsu N., Dawson T.M., Bredt D.S., Snyder S.H. Possible origins and distribution of immunoreactive nitric oxide synthasecontaining nerve fibers in cerebral arteries. Journal of Cerebral Blood Flow and Metabolism 1993; 13: 70–70
   PubMed Web of Science ®Google Scholar
• Welch K.M. Drug therapy of migraine. New England Journal of Medicine 1993; 329: 1476–1476
   PubMedGoogle Scholar
• Iversen H.K., Olesen J. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 1996; 16: 412–412
   PubMedGoogle Scholar
• Irikura K., Huang P.L., Ma J., Lee W.S., Dalkara T., Fishman M.C., Dawson T.M., Snyder S.H., Moskowitz M.A. Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 6823–6823
   PubMedGoogle Scholar
• Burnett A.L., Tillman S.L., Chang T.S., Epstein J.I., Lowenstein C.J., Bredt D.S., Snyder S.H., Walsh P.C. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. Journal of Urology 1993; 150: 73–73
   PubMed Web of Science ®Google Scholar
• Burnett A.L., Lowenstein C.J., Bredt D.S., Chang T.S., Snyder S.H. Nitric oxide: a physiologic mediator of penile erection. Science 1992; 257: 401–401
   PubMed Web of Science ®Google Scholar
• Rajfer J., Aronson W.J., Bush P.A., Dorey F.J., Ignarro L.J. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, non-cholinergic neurotransmission. New England Journal of Medicine 1992; 326: 90–90
   PubMed Web of Science ®Google Scholar
• Burnett A.L., Nelson R.J., Calvin D.C., Liu J.X., Demas G.E., Klein S.L., Kriegsfeld L.J., Dawson V.L., Dawson T.M., Snyder S.H. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase. Molecular Medicine 1996; 2: 288–288
   PubMed Web of Science ®Google Scholar
• Vernet D., Cai L., Garban H., Babbitt M.L., Murray F.T., Rajfer J., Gonzalez-Cadavid N.F. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 1995; 136: 5709–5709
   PubMed Web of Science ®Google Scholar
• Carrier S., Nagaraju P., Morgan D.M., Baba K., Nunes L., Lue T.F. Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. Journal of Urology 1997; 157: 1088–1088
   PubMed Web of Science ®Google Scholar
• Penson D.F., Ng C., Cai L., Rajfer J., Gonzalez-Cadavid N.F. Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat. Biology of Reproduction 1996; 55: 567–567
   PubMedGoogle Scholar
• Boolel M., Allen M.J., Ballard S.A., Gepi-Attee S., Muirhead G.J., Naylor A.M., Osterloh I.H., Gingell C. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. International Journal of Impotence Research 1996; 8: 47–47
   PubMedGoogle Scholar
• Ballard S.A., Gingell C.J., Tang K., Turner L.A., Price M.E., Naylor A.M. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. Journal of Urology 1998; 159: 2164–2164
   PubMed Web of Science ®Google Scholar
• Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. New England Journal of Medicine 1998; 338: 1397–1397
   PubMed Web of Science ®Google Scholar
• Chuang A.T., Strauss J.D., Murphy R.A., Steers W.D. Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. Journal of Urology 1998; 160: 257–257
   PubMed Web of Science ®Google Scholar
• Schuman E.M., Madison D.V. Nitric oxide and synaptic function. Annual Reviews of Neuroscience 1994; 17: 153–153
   PubMed Web of Science ®Google Scholar
• Shibuki K., Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 1991; 349: 326–326
   PubMed Web of Science ®Google Scholar
• Son H., Hawkins R.D., Martin K., Kiebler M., Huang P.L., Fishman M.C., Kandel E.R. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 1996; 87: 1015–1015
   PubMedGoogle Scholar
• Hirsch D.B., Steiner J.P., Dawson T.M., Mammen A., Hayek E., Snyder S.H. Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes. Current Biology 1993; 3: 749–749
   PubMedGoogle Scholar
• Lonart G., Wang J., Johnson K.M. Nitric oxide induces neurotransmitter release from hippocampal slices. European Journal of Pharmacology 1992; 220: 271–271
   PubMed Web of Science ®Google Scholar
• Dickie B.G., Lewis M.J., Davies J.A. NMDA-induced release of nitric oxide potentiates aspartate overflow from cerebellar slices. Neuroscience Letters 1992; 138: 145–145
   PubMedGoogle Scholar
• Montague P.R., Gancayco C.D., Winn M.J., Marchase R.B., Friedlander M.J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 1994; 263: 973–973
   PubMed Web of Science ®Google Scholar
• Hanbauer I., Wink D., Osawa Y., Edelman G.M., Gally J.A. Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices. Neuroreport 1992; 3: 409–409
   PubMedGoogle Scholar
• McCann S.M., Rettori V. The role of nitric oxide in reproduction. Proceedings of the Society for Experimental Biology and Medicine 1996; 211: 7–7
   PubMed Web of Science ®Google Scholar
• Rettori V., Belova N., Dees W.L., Nyberg C.L., Gimeno M., McCann S.M. Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 10130–10130
   PubMed Web of Science ®Google Scholar
• Mani S.K., Allen J.M., Rettori V., McCann S.M., O'Malley B.W., Clark J.H. Nitric oxide mediates sexual behavior in female rats. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 6468–6468
   PubMed Web of Science ®Google Scholar
• Rettori V., Canteros G., Renoso R., Gimeno M., McCann S.M. Oxytocin stimulates the release of luteinizing hormone-releasing hormone from medial basalhypothalamic explants by releasing nitric oxide. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 2741–2741
   PubMed Web of Science ®Google Scholar
• Wu H.H., Williams C.V., McLoon S.C. Involvement of nitric oxide in the elimination of a transient retinotectal projection in development. Science 1994; 265: 1593–1593
   PubMed Web of Science ®Google Scholar
• Hawkins R.D. NO honey, I don't remember. Neuron 1996; 16: 465–465
   PubMed Web of Science ®Google Scholar
• Kendrick K.M., Guevara-Guzman R., Zorrilla J., Hinton M.R., Broad K.D., Mimmack M., Ohkura S. Formation of olfactory memories mediated by nitric oxide. Nature 1997; 388: 670–670
   PubMed Web of Science ®Google Scholar
• Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993; 52: 127–127
   PubMed Web of Science ®Google Scholar
• Crosby G., Marota J.J., Huang P.L. Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase. Neuroscience 1995; 69: 1013–1013
   PubMedGoogle Scholar
• Silvagno F., Xia H., Bredt D.S. Neuronal nitric oxide synthase-m, an alternatively spliced isoform expressed in differentiated skeletal muscle. Journal of Biological Chemistry 1996; 271: 11204–11204
   PubMed Web of Science ®Google Scholar
• Kobzik L., Reid M.B., Bredt D.S., Stamler J.S. Nitric oxide in skeletal muscle. Nature 1994; 372: 546–546
   PubMed Web of Science ®Google Scholar
• Boczkowski J., Lanone S., Ungureanu-Longrois D., Danialou G., Fournier T., Aubier M. Induction of diaphragmatic nitric oxide synthase after endotoxin, administration in rats: role on diaphragmatic contractile dysfunction. Journal of Chemical Investigation 1996; 98: 1550–1550
   PubMedGoogle Scholar
• McAllister R.M., Hirai T., Musch T.I. Contribution of endothelium-derived nitric oxide (EDNO) to the skeletal muscle blood flow response to exercise. Medicine and Science in Sports and Exercise 1995; 27: 1145–1145
   PubMed Web of Science ®Google Scholar
• Corcondilas A., Koroxenidis G.T., Shepherd J.T. Effect of a brief contraction of forearm muscles on forearm blood flow. Journal of Applied Physiology 1964; 19: 142–142
   PubMed Web of Science ®Google Scholar
• Hussain S.N., Stewart D.J., Ludemann J.P., Magder S. Role of endothelium-derived relaxing factor in active hyperemia of the canine diaphragm. Journal of Applied Physiology 1992; 72: 2393–2393
   PubMedGoogle Scholar
• Hirai T., Visneski M.D., Kearns K.J., Zelis R., Musch T.I. Effects of NO synthase inhibition on the muscular blood flow response to treadmill exercise in rats. Journal of Applied Physiology 1994; 77: 1288–1288
   PubMedGoogle Scholar
• Dyke C.K., Proctor D.N., Dietz N.M., Joyner M.J. Role of nitric oxide in exercise hyperaemia during prolonged rhythmic handgripping in humans. Journal of Physiology 1995; 488: 259–259
   PubMedGoogle Scholar
• Anderson K.M., Faber J.E. Differential sensitivity of arteriolar alpha 1-and alpha 2-adrenoceptor constriction to metabolic inhibition during rat skeletal muscle contraction. Circulation Research 1991; 69: 174–174
   PubMed Web of Science ®Google Scholar
• Thomas G.D., Hansen J., Victor R.G. Inhibition of alpha 2-adrenergic vasoconstriction during contraction of glycolytic, not oxidative, rat hindlimb muscle. American Journal of Physiology 1994; 266: H920–H920
   PubMedGoogle Scholar
• Thomas G.D., Victor R.G. Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. Journal of Physiology 1998; 506: 817–817
   PubMed Web of Science ®Google Scholar
• Thomas G.D., Sander M., Lau K.S., Huang P.L., Stull J.T., Victor R.G. Proceedings of the National Academy of Sciences 1999, in press
   Google Scholar
• Brenman J.E., Chao D.S., Xia H., Aldape K., Bredt D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995; 82: 743–743
   PubMed Web of Science ®Google Scholar
• Brenman J.E., Chao D.S., Gee S.H., McGee A.W., Craven S.E., Santillano D.R., Huang F., Xia H., Peters M.F., Froehner S.C., Bredt D.S. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α-1 syntrophin mediated by PDZ motifs. Cell 1996; 84: 757–757
   PubMed Web of Science ®Google Scholar
• Chang W.J., Iannaccone S.T., Lau K.S., Masters B.S., McCabe T.J., McMillan K., Padre R.C., Spencer M.J., Tidball J.G., Stull J.T. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 9142–9142
   PubMed Web of Science ®Google Scholar
• Webster C., Silberstein L., Hays A.P., Blau H.M. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 1988; 52: 503–503
   PubMed Web of Science ®Google Scholar
• Lau K.S., Grange R.W., Chang W.J., Kamm K.E., Sarelius I., Stull J.T. Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Letters 1998; 431: 71–71
   PubMedGoogle Scholar
• Balon T.W., Nadler J.L. Evidence that nitric oxide increases glucose transport in skeletal muscle. Journal of Applied Physiology 1997; 82: 359–359
   PubMed Web of Science ®Google Scholar
• Tidball J.G., Lavergne B., Lau K.S., Spencer M.J., Stull J.T., Wehling M. Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle. American Journal of Physiology 1998; 275: C260–C260
   PubMedGoogle Scholar
• Chao D.S., Silvagno F., Bredt D.S. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. Journal of Neurochemistry 1998; 71: 784–784
   PubMedGoogle Scholar
• Crosbie R.H., Straub V., Yun H.Y., Lee J.C., Rafael J.A., Chamberlain J.S., Dawson V.L., Dawson T.M., Campbell K.P. mdx muscle pathology is independent of nNOS perturbation. Human Molecular Genetics 1998; 7: 823–823
   PubMed Web of Science ®Google Scholar
• Chao D.S., Gorospe R.M., Brenman J.E., Rafael J.A., Peters M.F., Froehner S.C., Hoffman E.P., Chamberlain J.S., Bredt D.S. Selective loss of sarcolemmal nitric oxide synthase in Becker Muscular Dystrophy. Journal of Experimental Medicine 1996; 184: 609–609
   PubMedGoogle Scholar
• Daniel E.E., Haugh C., Woskowska Z., Cipris S., Jury J., Fox-Threlkeld J.E. Role of nitric oxide-related inhibition in intestinal function: relation to vasoactive intestinal polypeptide. American Journal of Physiology 1994; 266: G31–G31
   PubMedGoogle Scholar
• Mashimo H., He X.D., Huang P.L., Fishman M.C., Goyal R.K. Neuronal constitutive nitric oxide synthase is involved in murine enteric inhibitory neurotransmission. Journal of Clinical Investigation 1996; 98: 8–8
   PubMedGoogle Scholar
• Kornau H.-C., Seeburg P.H., Kennedy M.B. Interaction of ion channels and receptors with PDZ domains. Current Opinions in Neurobiology 1997; 7: 368–368
   PubMed Web of Science ®Google Scholar
• Sheng M. PDZs and receptor/channel clustering: rounding up the latest suspects [comment]. Neuron 1996; 17: 575–575
   PubMedGoogle Scholar
• Jaffrey S.R., Snyder S.H. PIN: An associated protein inhibitor of neuronal nitric oxide synthase. Science 1996; 274: 774–774
   PubMed Web of Science ®Google Scholar
• Choi D.W. Glutamate receptors and the induction of excitotoxic neuronal death. Progress in Brain Research 1994; 100: 47–47
   PubMedGoogle Scholar
• Simon R.P., Swan J.H., Griffiths T., Meldrum B.S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 1984; 226: 850–850
   PubMed Web of Science ®Google Scholar
• Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 6368–6368
   PubMed Web of Science ®Google Scholar
• Dawson V.L., Kizushi V.M., Huang P.L., Snyder S.H., Dawson T.M. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. Journal of Neuroscience 1996; 16: 2479–2479
   PubMed Web of Science ®Google Scholar
• Dawson V.L., Dawson T.M. Nitric oxide in neuronal degeneration. Proceeding of the Society for Experimental Biology and Medicine 1996; 211: 33–33
   PubMed Web of Science ®Google Scholar
• Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994; 265: 1883–1883
   PubMed Web of Science ®Google Scholar
• Huang Z., Huang P.L., Ma J., Meng W., Ayata C., Fishman M.C., Moskowitz M.A. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. Journal of Cerebral Blood Flow and Metabolism 1996; 16: 981–981
   PubMed Web of Science ®Google Scholar
• Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends in Neuroscience 1997; 20: 132–132
   PubMed Web of Science ®Google Scholar
• Stamler J.S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78: 931–931
   PubMed Web of Science ®Google Scholar
• Drapier J.C., Hibbs J.B., Jr. Aconitases: a class of metalloproteins highly sensitive to nitric oxide synthesis. Methods in Enzymology 1996; 269: 26–26
   PubMed Web of Science ®Google Scholar
• Brown G.C. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Letters 1995; 369: 136–136
   PubMed Web of Science ®Google Scholar
• Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. A American Journal of Physiology 1996; 271: C1424–C1424
   PubMed Web of Science ®Google Scholar
• Kinouchi H., Epstein C.J., Mizui T., Carlson E., Chen S.F., Chan P.H. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 11158–11158
   PubMed Web of Science ®Google Scholar
• Samdani A.F., Dawson T.M., Dawson V.L. Nitric oxide synthase in models of focal ischemia. Stroke 1997; 28: 1283–1283
   PubMed Web of Science ®Google Scholar
• Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P., Bird E.D., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science 1985; 230: 561–561
   PubMed Web of Science ®Google Scholar
• Koh J.Y., Peters S., Choi D.W. Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity. Science 1986; 234: 73–73
   PubMed Web of Science ®Google Scholar
• Inagaki S., Suzuki K., Taniguchi N., Takagi H. Localization of Mn-superoxide dismutase (Mn-SOD) in cholinergic and somatostatin-containing neurons in the rat neostriatum. Brain Research 1991; 549: 174–174
   PubMedGoogle Scholar
• Galpern W.R., Matthews R.T., Beal M.F., Isacson O. NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease. Neuroreport 1996; 7: 2639–2639
   PubMedGoogle Scholar
• Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R.T., Beal M.F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Medicine 1996; 2: 1017–1017
   PubMed Web of Science ®Google Scholar
• Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 4565–4565
   PubMed Web of Science ®Google Scholar
• Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045–2045
   PubMed Web of Science ®Google Scholar
• Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997; 90: 537–537
   PubMed Web of Science ®Google Scholar
• Christopherson K.S., Bredt D.S. Nitric oxide in excitable tissues: physiological roles and disease. Journal of Clinical Investigation 1997; 100: 2424–2424
   PubMed Web of Science ®Google Scholar